j.ekstrom
Submits third-party assay reports on material purchased directly. Based in Antalya.
Section 1
Contribution
Purchases material, pays for assays, and submits the resulting reports to the index.
Records submitted
10
n=10
Annotations
0
n=0
Median purity submitted
99.48%
n=10
Suppliers covered
9
n=10
Section 2
Records submitted
A submitter chose to buy this material and to pay for this assay. That choice is the selection mechanism behind the whole index and it is not random.
| Report | Compound | Supplier | Lot | Lab | Quarter | Purity % | Water % | Recovery % | Provenance | Flags | Result |
|---|---|---|---|---|---|---|---|---|---|---|---|
| AX-2026-043089 | Ipamorelin | KP | KP-2606-D5887 | Medutest | 2026-Q3 | 99.07 | 3.67 | 89.4 | Supplier-supplied | 2 | MARGINAL |
| AX-2026-043459 | BPC-157 | WXT | WXT-2602-W4680 | Janoshik | 2026-Q2 | 98.27 | 5.34 | 105.5 | Supplier-supplied | 2 | MARGINAL |
| AX-2026-041623 | BPC-157 | QSC | QSC-2511-N8732 | Janoshik | 2026-Q2 | 99.93 | 5.81 | 104.3 | Supplier-supplied | 1 | MARGINAL |
| AX-2026-041756 | Selank | FGP | FGP-2511-D1094 | Janoshik | 2026-Q1 | 99.75 | 6.57 | 104.9 | Supplier-supplied | 0 | PASS |
| AX-2026-042845 | CJC-1295 with DAC | GGPeps | GGPE-2510-T1661 | VendorInvestigate | 2026-Q1 | 96.88 | 6.28 | — | Buyer-sourced | 1 | FAIL |
| AX-2025-020906 | GHRP-6 | CPC | CPC-2507-G2066 | Medutest | 2025-Q4 | 99.93 | 6.40 | — | Supplier-supplied | 4 | FAIL |
| AX-2025-020830 | GHRP-6 | SGN | SGN-2504-X1136 | PeptideMeter | 2025-Q3 | 98.45 | 4.24 | 98.1 | Laboratory-retained | 1 | FAIL |
| AX-2025-021170 | BPC-157 | WXT | WXT-2412-Y6192 | Kestrel | 2025-Q1 | 99.93 | 8.04 | — | Supplier-supplied | 2 | MARGINAL |
| AX-2024-004845 | BPC-157 | HJ | HJ-2407-D4137 | VendorInvestigate | 2024-Q4 | 99.33 | 7.49 | — | Laboratory-retained | 1 | MARGINAL |
| AX-2024-005536 | Semaglutide | BCH | BCH-2406-X8001 | Janoshik | 2024-Q3 | 99.64 | 3.02 | — | Supplier-supplied | 1 | MARGINAL |